SightfileU.S. market data from official filings

Companies › IOVA

IOVANCE BIOTHERAPEUTICS INC (IOVA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001425205 · EDGAR filings · Updated 2026-07-28

IOVANCE BIOTHERAPEUTICS INC (IOVA) has reported institutional ownership of 60.2%, with 283 institutional managers holding positions valued at $943.3M per the latest 13F reporting period.

Institutional ownership
60.2%
Institutional managers
283
Reported 13F value
$943.3M
Insider activity
55 trans.
$107.2K net buying

Filings this week (1)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, IOVANCE BIOTHERAPEUTICS INC has 283 institutional holders and institutional ownership of 60.2%.

Insider activity

Insiders reported 55 transactions (3 buys, 0 sells) across 7 reporting insiders, with a net reported value of $107.2K.

Related companies

FRESENIUS MEDICAL CARE AG (FMS) · PENNANT GROUP INC (PNTG) · NUVATION BIO INC (NUVB) · FORTREA HLDGS INC (FTRE) · CULLINAN THERAPEUTICS INC (CGEM) · COMPASS THERAPEUTICS INC (CMPX)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.